Drug intelligence / Profile preview

Tongluo Mingmu Capsule

Development stage
Unknown
Lead developer
Yiling Pharmaceutical
Administration
Oral
01

Overview

Tongluo Mingmu Capsule is a Traditional Chinese Medicine (TCM) formulation primarily developed and evaluated by The First Affiliated Hospital of Harbin Medical University for the treatment of non-proliferative diabetic retinopathy (NPDR). The therapeutic approach of the capsule is based on the TCM principles of "Tongluo" (dredging collaterals) and "Mingmu" (improving eyesight), which translate to improving microcirculation and protecting retinal health. It is intended to address the underlying pathology of diabetic retinopathy, such as retinal ischemia and increased vascular permeability, by modulating inflammatory pathways and potentially inhibiting vascular endothelial growth factor (VEGF) expression. Clinical studies, including Phase 4 trials in China, aim to confirm its efficacy in stabilizing or improving visual acuity and reducing retinal lesions in patients with type 2 diabetes.

Brand names
Tongluo Mingmu Capsule
Other names
Tongluo Mingmu Jiaonang
02

Targets

Beyond the preview

Go deeper on Tongluo Mingmu Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongluo Mingmu Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call